4D Molecular Therapeutics (FDMT) Shares Outstanding (2019 - 2026)
4D Molecular Therapeutics (FDMT) Shares Outstanding (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | 4D Molecular Therapeutics | 706.51 Mn | 315.62 Mn | - | 68.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.06 Mn |
| Dec 31, 2025 | 57.93 Mn |
| Sep 30, 2025 | 56.13 Mn |
| Jun 30, 2025 | 55.93 Mn |
| Mar 31, 2025 | 55.74 Mn |
| Dec 31, 2024 | 53.94 Mn |
| Sep 30, 2024 | 55.55 Mn |
| Jun 30, 2024 | 55.28 Mn |
| Mar 31, 2024 | 49.27 Mn |
| Dec 31, 2023 | 39.13 Mn |
| Sep 30, 2023 | 42.26 Mn |
| Jun 30, 2023 | 38.34 Mn |
| Mar 31, 2023 | 32.72 Mn |
| Dec 31, 2022 | 32.35 Mn |
| Sep 30, 2022 | 32.39 Mn |
| Jun 30, 2022 | 32.32 Mn |
| Mar 31, 2022 | 32.23 Mn |
| Dec 31, 2021 | 27.73 Mn |
| Sep 30, 2021 | 27.02 Mn |
| Jun 30, 2021 | 26.74 Mn |